Infectious Disease
Complicated Appendicitis
7
Pipeline Programs↗
4
Active Trials↗
7
Companies Involved↗
Complicated Appendicitis is an early-stage landscape with 7 programs across 7 companies. The most active players are Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Melinta Therapeutics, Inc., Bayer. 4 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Analysis
Trial Status
12
clinical trials
Completed5 · 42%
Unknown status2 · 17%
Not yet recruiting2 · 17%
Terminated1 · 8%
Enrolling by invitation1 · 8%
Recruiting1 · 8%
Clinical Trials
Trial Activity
12 trials
Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics
Recruiting·FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau·Phase 4·NCT05761080·772 enrolled
Laparoscopic Antibiotic Lavage to Prevent Intra-abdominal Abscess Formation in Complicated Appendicitis
Not yet recruiting·—·Phase 3·NCT06841003·752 enrolled
Conservative Versus Operative ManageMent of Acute Uncomplicated Appendicitis
Completed·—·N/A·NCT02916134·186 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)